Featured Story Esketamine: A New Approach for Patients with Treatment-Resistant Depression
For patients with intractable depression, a new esketamine clinic — among the first in the U.S. — can provide immediate relief.
Brainwise Fall 2019
The Newsletter of the Johns Hopkins Department of Psychiatry and Behavioral Sciences
Articles in this Issue
-
Lab Studies Dive Headfirst into Pathways Touched by Schizophrenia
A series of studies using suforaphane — a natural compound derived from broccoli sprouts — showed potential to tweak chemical imbalances in the brains of people with schizhophrenia.
-
Low-Cost Intervention Reduces Risk of Opioid Overdose
A new online, self-paced tutorial about opioids improves knowledge and reduces risky behaviors.
-
New Psychiatry Residency Tracks: More Mentorship and Career Development
Four new scholarly tracks make it possible for residents to develop an area of expertise, aided by faculty mentors.
-
Of Grants, Innovation and Clinical Support
Psychiatry Director Jimmy Potash shares the latest news and promising developments from the department.
